When was Volumetric founded?

Volumetric was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Where is Volumetric located?

Volumetric is headquartered in Houston, United States.

How many employees does Volumetric have?

As of Aug 31, 2026, the latest employee count at Volumetric is 15.

Is Volumetric a funded company?

Volumetric is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Mar 17, 2020.

How much is Volumetric worth?

The last known valuation of Volumetric was $***** as of Mar 17, 2020.

When was the latest funding round of Volumetric?

Volumetric's latest funding was a $***** Seed round on Mar 17, 2020, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.29B in funding in 2026 to date.

Where does Volumetric rank among its competitors?

Volumetric ranks 236th amongst 2108 active competitors, of which 463 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was One Biosciences, which secured $3.76M in Sep, 2026.

Who are the top competitors of Volumetric?

Volumetric's top competitors include Aspect Biosystems, Antheia and Transcenta. Among them, One Biosciences secured the most recent funding round in September, 2026.

Volumetric - 2026 Company Profile, Team, Funding & Competitors

Q: Is Volumetric an acquired company?

Volumetric got acquired by 3D Systems on Oct 27, 2021.

Volumetric is an acquired company based in Houston (United States), founded in 2018 by Jordan Miller and Bagrat Grigoryan. It operates as a Provide of reagents and 3D bio-printers for biofabrication. Volumetric has raised $125K in funding from Y Combinator, with last known valuation of $*****. The company has 2108 active competitors, including 463 funded and 331 that have exited. Its top competitors include companies like Aspect Biosystems, Antheia and Transcenta.

Company Details

Volumetric is a provider of reagents and 3D bio-printers for biofabrication. The company has developed a light-based bioprinting platform. The company provides bioprinters and bio-inks for application in the life sciences, drug discovery, and medical devices. It provides custom bioprinter, Lumen X bioprinter reagents like 6000 Da polyethylene glycol, lithium phenyl-2,4,6-trimethyl-benzoyl phosphinate (LAP) photoinitiator, carbohydrate glass, and Gel MA.

Website: volumetricbio.com
Social

Key Metrics

Founded Year

2018

Location

Houston, United States

Stage

Acquired

Total Funding

$125K in 1 round

Latest Funding Round

Seed, Mar 17, 2020, $*****

Last Known Valuation

$***** as on Mar 17, 2020

Investors

Y Combinator & 16 more

Ranked

236^th among 2108 active competitors

Employee Count

15 as on Aug 31, 2026

Similar Companies

Aspect Biosystems & 2780 more

Exit Details

Acquired by 3D Systems (Oct 27, 2021)

View Volumetric's full profile

Volumetric got acquired by 3D Systems on Oct 27, 2021 at an acquisition amount of $*****.

Click here to take a look at Volumetric's acquisition in detail

Volumetric has raised a total funding of $125K over 1 round. Its latest funding round was a Seed round on Mar 17, 2020 for $*****. 1 investor participated in its latest round. Volumetric has 16 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Volumetric:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 17, 2020	2738596	Seed	5949082	6718414	9458091	1104661

Access funding benchmarks and valuations. Sign up today!

View details of Volumetric's funding rounds and investors

The founders of Volumetric are Jordan Miller and Bagrat Grigoryan.

Here are the details of Volumetric's key team members:

Jordan Miller: Co-Founder of Volumetric.
Bagrat Grigoryan: COO, Co-Founder of Volumetric.

View details of Volumetric's Founder profiles and Board Members

Volumetric's employee count trend

Volumetric has 15 employees as of Aug 26. Here is Volumetric's employee count trend over the years:

Uncover Volumetric's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Volumetric include Aspect Biosystems, Antheia and Transcenta. Here is the list of Top 10 competitors of Volumetric, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aspect Biosystems 2013, Vancouver (Canada), Series B	Developer of bioprinting technology and tissue therapeutics for regenerative medicine	$139M	Pangaea Ventures, Dimension & 21 others	68/100
2nd	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
3rd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
4th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Loayal Valley Capital, Sino Biopharmaceutical ... & 18 others	65/100
5th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Atlas Venture ... & 14 others	64/100
6th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	64/100
7th	Fermentalg 2005, Libourne (France), Public	Innovating with algae for sustainable solutions in nutrition and environmental impact	$30.3M	Demeter, Smalt Capital & 14 others	63/100
8th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	TA Associates, UBS & 1 others	63/100
9th	LifeMine Therapeutics 2016, Watertown (United States), Series E	Developer of novel drugs from fungi via genome mining and recombinant overexpression	$563M	Fidelity Investments, 6 Dimensions Capital ... & 17 others	63/100
10th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 7 others	63/100
236th	Volumetric 2018, Houston (United States), Acquired	Provide of reagents and 3D bio-printers for biofabrication	$125K	TMT Investments, Transolam & 15 others	42/100